Format
Sort by
Items per page

Send to

Choose Destination

Best matches for melanoma, metastatic OR melanoma:

Radiofrequency ablation in metastatic melanoma. Shashank A et al. J Surg Oncol. (2014)

New drug targets in metastatic melanoma. Homet B et al. J Pathol. (2014)

Management of melanoma. Corrie P et al. Br Med Bull. (2014)

Search results

Items: 1 to 20 of 117994

1.

Compartment-Specific Biosensors Reveal a Complementary Subcellular Distribution of Bioactive Furin and PC7.

Ginefra P, Filippi BGH, Donovan P, Bessonnard S, Constam DB.

Cell Rep. 2018 Feb 20;22(8):2176-2189. doi: 10.1016/j.celrep.2018.02.005.

PMID:
29466742
2.

Anti-programmed cell death-1 (PD-1) monoclonal antibodies in treating advanced melanoma -- a clinical update.

Trinh VA, Joseph J, Hwu WJ.

Discov Med. 2018 Jan;25(135):31-40.

PMID:
29466692
3.

Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Khan AQ, Travers JB, Kemp MG.

Environ Mol Mutagen. 2018 Feb 21. doi: 10.1002/em.22176. [Epub ahead of print] Review.

PMID:
29466611
4.

Dermoscopy and Overdiagnosis of Melanoma In Situ.

Nufer KL, Raphael AP, Soyer HP.

JAMA Dermatol. 2018 Feb 21. doi: 10.1001/jamadermatol.2017.6448. [Epub ahead of print] No abstract available.

PMID:
29466567
5.

Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ.

Lallas A, Longo C, Manfredini M, Benati E, Babino G, Chinazzo C, Apalla Z, Papageorgiou C, Moscarella E, Kyrgidis A, Argenziano G.

JAMA Dermatol. 2018 Feb 21. doi: 10.1001/jamadermatol.2017.6447. [Epub ahead of print]

PMID:
29466542
6.

Loss-of-function mutations in filaggrin gene and malignant melanoma.

Kezic S.

J Eur Acad Dermatol Venereol. 2018 Feb;32(2):193. doi: 10.1111/jdv.14813. No abstract available.

PMID:
29465831
7.

Orbital invasion routes of non-melanoma skin cancers and survival outcomes.

Dundar Y, Cannon R, Wiggins R, Monroe MM, Buchmann LO, Hunt JP.

Orbit. 2018 Feb 21:1-6. doi: 10.1080/01676830.2018.1439070. [Epub ahead of print]

PMID:
29465316
8.

Cutaneous melanoma: an updated SIGN Guideline.

Brown ER, Fraser SJ, Quaba O, Simms A, Stein A.

J R Coll Physicians Edinb. 2017 Sep;47(3):214-217. doi: 10.4997/JRCPE.2017.302. No abstract available.

PMID:
29465095
10.

An improved strategy for skin lesion detection and classification using uniform segmentation and feature selection based approach.

Nasir M, Attique Khan M, Sharif M, Lali IU, Saba T, Iqbal T.

Microsc Res Tech. 2018 Feb 21. doi: 10.1002/jemt.23009. [Epub ahead of print]

PMID:
29464868
11.

Desmoplastic transformation of a nodular melanoma arising from a speckled lentiginous nevus.

Miura K, Namiki T, Akashi T, Uemura N, Mori H, Yokozeki H, Okazaki M.

J Dermatol. 2018 Feb 21. doi: 10.1111/1346-8138.14266. [Epub ahead of print] No abstract available.

PMID:
29464760
12.

Safety and efficacy of nivolumab in Japanese patients with malignant melanoma: An interim analysis of a postmarketing surveillance.

Kiyohara Y, Uhara H, Ito Y, Matsumoto N, Tsuchida T, Yamazaki N.

J Dermatol. 2018 Feb 20. doi: 10.1111/1346-8138.14227. [Epub ahead of print]

PMID:
29464755
13.

Tumor Targeting via Sialic Acid: [68Ga]DOTA-en-pba as a New Tool for Molecular Imaging of Cancer with PET.

Tsoukalas C, Geninatti-Crich S, Gaitanis A, Tsotakos T, Paravatou-Petsotas M, Aime S, Jiménez-Juárez R, Anagnostopoulos CD, Djanashvili K, Bouziotis P.

Mol Imaging Biol. 2018 Feb 20. doi: 10.1007/s11307-018-1176-0. [Epub ahead of print]

PMID:
29464496
14.

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.

Riechardt AI, Klein JP, Cordini D, Heufelder J, Rehak M, Seibel I, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2018 Feb 20. doi: 10.1007/s00417-018-3929-5. [Epub ahead of print]

PMID:
29464331
15.

Unclassified sclerosing malignant melanomas with AKAP9-BRAF gene fusion: a report of two cases and review of BRAF fusions in melanocytic tumors.

Perron E, Pissaloux D, Neub A, Hohl D, Tartar MD, Mortier L, Alberti L, de la Fouchardiere A.

Virchows Arch. 2018 Feb 21. doi: 10.1007/s00428-017-2290-0. [Epub ahead of print]

PMID:
29464327
16.

You should get that mole checked out: Ethical and legal considerations of the unsolicited clinical opinion.

Adler NR, Mahar PD, Kelly JW.

Aust Fam Physician. 2017 Dec;46(12):949-951.

PMID:
29464234
17.

Survival and Failure Outcomes Predicted by Brain Metastasis Volumetric Kinetics in Melanoma Patients Following Upfront Treatment with Stereotactic Radiosurgery Alone.

LeCompte MC, McTyre E, Henson A, Farris M, Okoukoni C, Cramer CK, Triozzi P, Ruiz J, Watabe K, Lo HW, Munley MT, Laxton AW, Tatter SB, Zhou X, Chan M.

Cureus. 2017 Dec 11;9(12):e1934. doi: 10.7759/cureus.1934.

PMID:
29464141
18.

Combined inhibition of CDK and HDAC as a promising therapeutic strategy for both cutaneous and uveal metastatic melanoma.

Heijkants R, Willekens K, Schoonderwoerd M, Teunisse A, Nieveen M, Radaelli E, Hawinkels L, Marine JC, Jochemsen A.

Oncotarget. 2017 Dec 15;9(5):6174-6187. doi: 10.18632/oncotarget.23485. eCollection 2018 Jan 19.

PMID:
29464063
19.

Cell-cell fusion as a mechanism of DNA exchange in cancer.

Searles SC, Santosa EK, Bui JD.

Oncotarget. 2017 Dec 27;9(5):6156-6173. doi: 10.18632/oncotarget.23715. eCollection 2018 Jan 19.

PMID:
29464062
20.

[Neratinib + Valproate] exposure permanently reduces ERBB1 and RAS expression in 4T1 mammary tumors and enhances M1 macrophage infiltration.

Booth L, Roberts JL, Rais R, Kirkwood J, Avogadri-Connors F, Cutler RE Jr., Lalani AS, Poklepovic A, Dent P.

Oncotarget. 2017 Dec 26;9(5):6062-6074. doi: 10.18632/oncotarget.23681. eCollection 2018 Jan 19.

PMID:
29464055

Supplemental Content

Loading ...
Support Center